Pharmaceuticals

600+ Companies
More info
Parent markets
Sibling markets
Related markets
600+ companies in Pharmaceuticals
Show all
Merck

Merck

Health Care +2
AbbVie

AbbVie

Biotechnology +1
GlaxoSmithKline

GlaxoSmithKline

Health and Wellness +2
Roche

Roche

Biotechnology +3
Sanofi

Sanofi

Pharmaceuticals
Allergan plc

Allergan plc

Biotechnology +1
TransEnterix

TransEnterix

Health Care +2
AstraZeneca

AstraZeneca

Biotechnology +1
Takeda

Takeda

Health Care +1
Bristol-Myers Squibb

Bristol-Myers Squibb

Health and Wellness +2
Intrexon

Intrexon

Biotechnology +2
Novo Nordisk

Novo Nordisk

Biotechnology +1
Galena Biopharma

Galena Biopharma

Biotechnology +1
AlternaCare

AlternaCare

Medical +2
Atomwise

Atomwise

Artificial Intelligence +2
All companies in Pharmaceuticals
Terms of Service Privacy Policy Privacy Settings Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

Companies
687
Established hub
Add companies
Deals 2018 Q4
17 investments
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
Upgrade account
Reuters

Jazz Pharma's sleep disorder treatment gets FDA nod

New York Times Bits

Why Should Americans Be Grateful for $138 Insulin? Germans Get It for $55

The Guardian

Fake drugs kill more than 250,000 children a year, doctors warn

Robotics
PE Hub

PE-backed ProPharma acquires Southwood Research

Reuters

Dutch join backlash at expensive drugs by making their own

Robotics
Ars Technica

Shkreli directing notorious pharma co. from prison. It’s still losing millions

MedCity News

Report: Martin Shkreli runs his latest drug company from prison

Reuters

Vertex cystic fibrosis triple combo therapy succeeds in important...

PE Hub

Pacira to acquire VC-backed MyoScience

Myoscience
Myoscience
Xconomy

Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3

Xconomy

Data in Hand, Alnylam To Seek OK For Second RNAi Drug

Alnylam
Alnylam
MedCity News

Report: Scott Gottlieb resigns as FDA commissioner

PE Hub

Catalyst Clinical buys certain Triangle Biostatistics assets

Xconomy

Lilly to Launch “Authorized Generic” Insulin Priced at 50% Discount

New York Times Bits

Drug Companies and Doctors Battle Over the Future of Fecal Transplants

Robotics
Reuters

New cancer-causing toxin found in recalled blood pressure pills

Xconomy

Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark

Roche
Roche
Xconomy

Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans

Robotics
Xconomy

Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington

Celgene Corporation
Celgene Corporation
Bristol-Myers Squibb
Bristol-Myers Squibb
Xconomy

Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away